Form 4: Avita Medical Director Jan Stern Reed Acquires Shares and Stock Options

Director Jan Stern Reed of Avita Medical, Inc. reports acquisition of common stock and stock options.

Summary

• On June 5, 2024, Jan Stern Reed, a director of Avita Medical, Inc., acquired 9,200 shares of common stock.
• These shares were obtained through an award of Restricted Stock Units (RSUs) that vest 12 months after the grant date.
• Reed also acquired stock options for 3,943 shares of common stock with an exercise price of $9.51, exercisable from June 5, 2025, to June 5, 2034.
• Following these transactions, Reed directly owns 40,989 shares of common stock, including unvested RSUs, and holds options for 3,943 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider trading activity. The acquisition of shares and options by a director could be seen as a positive signal, but it's not definitively bullish.

Positives

• The director's acquisition of shares and options may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like directors and officers, trade in their company's stock. These filings provide transparency to the market and allow investors to track insider activity, which can sometimes offer insights into a company's prospects.

Stakeholder Impact

• Shareholders may view the director's stock acquisition as a positive sign, potentially increasing investor confidence.

Key Dates